Clinical usefulness of the CSF β-amyloid Aβ1-42/Aβ1-40 ratio for Alzheimer's disease diagnosis: a retrospective study in a Belgian academic hospital

被引：0
|
作者：
Deltombe, Matthieu [1 ,2 ]
Fillee, Catherine [1 ,2 ]
van Pesch, Vincent [3 ,4 ]
机构：
[1] Clin Univ St Luc, Dept Clin Biochem, Brussels, Belgium
[2] Catholic Univ Louvain, Brussels, Belgium
[3] Clin Univ St Luc, Dept Neurol, B-1200 Brussels, Belgium
[4] Catholic Univ Louvain, UClouvain, 10 Ave Hippocrate, B-1200 Brussels, Belgium
来源：
ACTA NEUROLOGICA BELGICA | 2022年 / 122卷 / 01期
关键词：
Alzheimer; A beta 1-42; A beta 1-40; Ratio; Cerebrospinal fluid; BIOMARKERS;
D O I：
10.1007/s13760-021-01846-4
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：245 / 247
页数：3
相关论文
共 50 条
  • [21] Study of plasma levels of Aβ1-42, Aβ1-40, and p-tau in Alzheimer disease
    Peng, D
    Cai, X
    Xu, X
    Wang, X
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (04): : 614 - 615
  • [22] Comparison of Alzheimer Aβ(1-40) and Aβ(1-42) amyloid fibrils reveals similar protofilament structures
    Schmidt, Matthias
    Sachse, Carsten
    Richter, Walter
    Xu, Chen
    Faendrich, Marcus
    Grigorieff, Nikolaus
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (47) : 19813 - 19818
  • [23] Comparison of Alzheimer's amyloid-β(1-40) and amyloid-β(1-42) fibrils as determined by solution NMR spectroscopy
    Olofsson, A.
    Lindhagen-Persson, M.
    Sauer-Eriksson, A. E.
    Ohman, A.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2006, 13 : 50 - 50
  • [24] The free plasma amyloid A β 1-42 /A β 1-40 ratio predicts conversion to dementia for subjects with mild cognitive impairment with performance equivalent to that of the total plasma A β 1-42 /A β 1-40 ratio. The BALTAZAR study
    Schraen-Maschke, S.
    Duhamel, A.
    Vidal, J. S.
    Ramdane, N.
    Vaudran, L.
    Dussart, C.
    Buee, L.
    Sablonniere, B.
    Delaby, C.
    Allinquant, B.
    Gabelle, A.
    Bombois, S.
    Lehmann, S.
    Hanon, O.
    NEUROBIOLOGY OF DISEASE, 2024, 193
  • [25] Efflux of human and mouse amyloid β proteins 1-40 and 1-42 from brain:: Impairment in a mouse model of Alzheimer's disease
    Banks, WA
    Robinson, SM
    Verma, S
    Morley, JE
    NEUROSCIENCE, 2003, 121 (02) : 487 - 492
  • [26] Amyloid β protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease
    Mehta, PD
    Pirttila, T
    Patrick, BA
    Barshatzky, M
    Mehta, SP
    NEUROSCIENCE LETTERS, 2001, 304 (1-2) : 102 - 106
  • [27] Gelsolin bound β-amyloid peptides(1-40/1-42): Electrochemical evaluation of levels of soluble peptide associated with Alzheimer's disease
    Yu, Yanyan
    Sun, Xiaoyu
    Tang, Daoquan
    Li, Chenglin
    Zhang, Lin
    Nie, Dongxia
    Yin, Xiaoxing
    Shi, Guoyue
    BIOSENSORS & BIOELECTRONICS, 2015, 68 : 115 - 121
  • [28] Longitudinal study of cerebrospinal fluid levels of tau, Aβ1-40, and Aβ1-42(43) in Alzheimer's disease:: A study in Japan
    Kanai, M
    Matsubara, E
    Isoe, K
    Urakami, K
    Nakashima, K
    Arai, H
    Sasaki, H
    Abe, K
    Iwatsubo, T
    Kosaka, T
    Watanabe, M
    Tomidokoro, Y
    Shizuka, M
    Mizushima, K
    Nakamura, T
    Igeta, Y
    Ikeda, Y
    Amari, M
    Kawarabayashi, T
    Ishiguro, K
    Harigaya, Y
    Wakabayashi, K
    Okamoto, K
    Hirai, S
    Shoji, M
    ANNALS OF NEUROLOGY, 1998, 44 (01) : 17 - 26
  • [29] Familial Alzheimer's disease-linked presenilin 1 variants elevate A beta 1-42/1-40 ratio in vitro and in vivo
    Borchelt, DR
    Thinakaran, G
    Eckman, CB
    Lee, MK
    Davenport, F
    Ratovitsky, T
    Prada, CM
    Kim, G
    Seekins, S
    Yager, D
    Slunt, HH
    Wang, R
    Seeger, M
    Levey, AI
    Gandy, SE
    Copeland, NG
    Jenkins, NA
    Price, DL
    Younkin, SG
    NEURON, 1996, 17 (05) : 1005 - 1013
  • [30] CSF beta-amyloid 1-42 - what are we measuring in Alzheimer's disease?
    Hu, William T.
    Watts, Kelly D.
    Shaw, Leslie M.
    Howell, Jennifer C.
    Trojanowski, John Q.
    Basra, Sundeep
    Glass, Jonathan D.
    Lah, James J.
    Levey, Allan I.
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2015, 2 (02): : 131 - 139
12345